What does CUSIP 92764N102 represent in this 13F holders report?

CUSIP 92764N102 is the security identifier for VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

How many institutions held VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value in Q2 2020?

109 institutional investors reported VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value for Q2 2020. Use the holders table for investor-level position and value details.

Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)

CUSIP: 92764N102

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 168,432,200
Total 13F shares: 53,528,634
Share change: +15,680,042
Total reported value: $2,192,860,452
Put/Call ratio: 113%
Price per share: $40.97
Number of holders: 109
Value change: +$657,421,714
Number of buys: 96
Number of sells: 15

Quarterly Holders Quick Answers

What is CUSIP 92764N102?
CUSIP 92764N102 identifies VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 92764N102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SB INVESTMENT ADVISERS (UK) LTD	13F	Company	13%	22,616,666	$775,073,000	—	31 Mar 2020	13F
Temasek Holdings (Private) Ltd	13F	Company	3.3%	5,499,999	$188,485,000	—	31 Mar 2020	13F
ICONIQ Capital, LLC	13F	Company	2%	3,333,333	$114,233,000	—	31 Mar 2020	13F
Alphabet Inc.	13F	Company	0.99%	1,666,666	$57,117,000	—	31 Mar 2020	13F
Alaska Permanent Fund Corp	13F	Company	0.89%	1,500,000	$51,405,000	—	31 Mar 2020	13F
Capital International Investors	13F	Company	0.65%	1,094,305	$37,502,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	0.26%	443,818	$15,209,000	—	31 Mar 2020	13F
EcoR1 Capital, LLC	13F	Company	0.16%	270,418	$9,267,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	0.11%	177,320	$6,077,000	—	31 Mar 2020	13F
BAILLIE GIFFORD & CO	13F	Company	0.08%	129,869	$4,451,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	0.08%	126,378	$4,331,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.07%	121,647	$4,169,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	116,280	$3,984,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.06%	109,228	$3,744,000	—	31 Mar 2020	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.05%	91,977	$3,152,000	—	31 Mar 2020	13F
INDUS CAPITAL PARTNERS, LLC	13F	Company	0.05%	87,638	$3,003,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.03%	58,500	$2,005,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.03%	53,765	$1,843,000	—	31 Mar 2020	13F
Board of Trustees of The Leland Stanford Junior University	13F	Company	0.02%	38,905	$1,333,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.02%	36,704	$1,257,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.02%	26,058	$893,000	—	31 Mar 2020	13F
Qube Research & Technologies Ltd	13F	Company	0.02%	25,867	$886,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.01%	21,800	$747,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.01%	19,617	$672,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.01%	18,386	$630,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.01%	15,197	$521,000	—	31 Mar 2020	13F
CHICAGO EQUITY PARTNERS LLC	13F	Company	0.01%	13,829	$474,000	—	31 Mar 2020	13F
Harvest Investment Services, LLC	13F	Company	0.01%	13,325	$456,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	11,960	$410,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.01%	11,517	$395,000	—	31 Mar 2020	13F
AMUNDI ASSET MANAGEMENT US, INC.	13F	Company	0.01%	11,200	$384,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	11,133	$382,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.01%	11,100	$380,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	10,554	$362,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0%	8,310	$285,000	—	31 Mar 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0%	8,200	$281,000	—	31 Mar 2020	13F
MYDA Advisors LLC	13F	Company	0%	7,500	$257,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0%	7,030	$241,000	—	31 Mar 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	6,611	$227,000	—	31 Mar 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	4,265	$146,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0%	4,187	$143,000	—	31 Mar 2020	13F
MetLife Investment Management, LLC	13F	Company	0%	3,382	$115,901	—	31 Mar 2020	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	2,800	$96,000	—	31 Mar 2020	13F
CITIGROUP INC	13F	Company	0%	2,645	$91,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0%	2,491	$86,000	—	31 Mar 2020	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0%	2,499	$85,641	—	31 Mar 2020	13F
STRS OHIO	13F	Company	0%	1,900	$65,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1,725	$59,000	—	31 Mar 2020	13F
Legal & General Group Plc	13F	Company	0%	1,129	$39,000	—	31 Mar 2020	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	620	$21,000	—	31 Mar 2020	13F

Institutional Holders of Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) as of Q2 2020

As of 30 Jun 2020, Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,528,634 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, Temasek Holdings (Private) Ltd, Alaska Permanent Fund Corp, BlackRock Inc., BAILLIE GIFFORD & CO, ICONIQ Capital, LLC, ALLIANCEBERNSTEIN L.P., Capital International Investors, JANUS HENDERSON GROUP PLC, and STATE STREET CORP. This page lists 109 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

109

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.